GSK (FKA GLAXOSMITHKLINE INC.)

DC
Filings
82
Firms Hired
1
Total Expenses
$99,352,000
Years Active
2007–2026

Filings

All 20262025202420232022202120202019201820172016201520142013201220112010200920082007
YearFirmPeriodExpensesDoc
2026 GSK (FKA GLAXOSMITHKLINE INC.) 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$1,640,000
2025 GSK (FKA GLAXOSMITHKLINE INC.) 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$810,000
2025 GSK (FKA GLAXOSMITHKLINE INC.) 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$1,700,000
2025 GSK (FKA GLAXOSMITHKLINE INC.) 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$1,510,000
2025 GSK (FKA GLAXOSMITHKLINE INC.) 1st Quarter (Jan 1 - Mar 31)
AMENDED 		$800,000
2025 GSK (FKA GLAXOSMITHKLINE INC.) 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$800,000
2024 GSK (FKA GLAXOSMITHKLINE INC.) 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$920,000
2024 GSK (FKA GLAXOSMITHKLINE INC.) 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$1,540,000
2024 GSK (FKA GLAXOSMITHKLINE INC.) 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$1,510,000
2024 GSK (FKA GLAXOSMITHKLINE INC.) 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$820,000
Page 1 of 9  ·  82 filings Next
Firms Hired
FirmFilingsExpenses
GSK (FKA GLAXOSMITHKLINE INC.) 82 $99,352,000
Issue Areas
IssueActivities
Health Issues 82
Copyright/Patent/Trademark 82
Medicare/Medicaid 82
Trade (domestic/foreign) 70
Budget/Appropriations 67
Taxation/Internal Revenue Code 36
Medical/Disease Research/Clinical Labs 15
Tariff (miscellaneous tariff bills) 8
Government Issues 5
Torts 4
Labor Issues/Antitrust/Workplace 2
Defense 1
Financial Institutions/Investments/Securities 1
Pharmacy 1

Bills Mentioned in Filings

S. 2023 H.R. 1 H.R. 5376 S. 2076 H.R. 3932 H.R. 5376 H.R. 2873 S. 773 S. 154 S. 920 S. 164 H.R. 3 S. 259 S. 562 H.R. 1976 H.R. 2148 H.R. 19 S. 415 H.R. 724 H.R. 2139 S. 1435 H.R. 2181 S. 1644 S. 1428 S. 1645